-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
*It is only for medical professionals to read for reference.
More than one-third of diabetic patients have CKD, but with the loss of kidney function, the patient's medication is gradually restricted.
How to choose a hypoglycemic plan for the patient due to "disease" conditions? Read the full text and find the answer at the end of the article.Answer: C Basal Insulin Did you get the correct answer? References: [1]GBD Chronic Kidney Disease Collaboration.
Lancet.
2020;395(10225):709-733.
[2]Zhang L, et al.
Lancet.
2012;378(8878):815-822.
[3] Kaifeng Guo, et al.
J Diabetes Complications.
2016;30(5):803-10.
[4] Expert Group of Nephrology Branch of Chinese Medical Association.
Chinese Journal of Nephrology.
2021;37(3):255-304.
[5]Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group.
Kidney Int.
2020;98(4S):S1-S115.
[6]Luk AO, et al.
Diabet Med.
Diabet Med.
2016;33(9 ):1230-9.
[7]2018 USRDS Annual Data Report.
[8]Zoungas S, et al.
Diabetologia 2012;55(3):636–643.
[9]Moen MF, et al.
Clin J Am Soc Nephrol .
2009;4:1121–1127.
[10]Alsahli M and Gerich JE.
Mayo Clin Proc.
2014;89:1564–71.
[11]Yu TM, et al.
Neurology.
2014;83(8):686- 94.
[12]UK Prospective Diabetes Study (UKPDS) Group.
Lancet.
1998;352(9131):837-53.
[13]Wong MG, et al.
Diabetes Care.
2016;39(5):694-700.
[14]Alsahli M and Gerich JE.
J Clin Med.
More than one-third of diabetic patients have CKD, but with the loss of kidney function, the patient's medication is gradually restricted.
How to choose a hypoglycemic plan for the patient due to "disease" conditions? Read the full text and find the answer at the end of the article.Answer: C Basal Insulin Did you get the correct answer? References: [1]GBD Chronic Kidney Disease Collaboration.
Lancet.
2020;395(10225):709-733.
[2]Zhang L, et al.
Lancet.
2012;378(8878):815-822.
[3] Kaifeng Guo, et al.
J Diabetes Complications.
2016;30(5):803-10.
[4] Expert Group of Nephrology Branch of Chinese Medical Association.
Chinese Journal of Nephrology.
2021;37(3):255-304.
[5]Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group.
Kidney Int.
2020;98(4S):S1-S115.
[6]Luk AO, et al.
Diabet Med.
Diabet Med.
2016;33(9 ):1230-9.
[7]2018 USRDS Annual Data Report.
[8]Zoungas S, et al.
Diabetologia 2012;55(3):636–643.
[9]Moen MF, et al.
Clin J Am Soc Nephrol .
2009;4:1121–1127.
[10]Alsahli M and Gerich JE.
Mayo Clin Proc.
2014;89:1564–71.
[11]Yu TM, et al.
Neurology.
2014;83(8):686- 94.
[12]UK Prospective Diabetes Study (UKPDS) Group.
Lancet.
1998;352(9131):837-53.
[13]Wong MG, et al.
Diabetes Care.
2016;39(5):694-700.
[14]Alsahli M and Gerich JE.
J Clin Med.
